Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Magurol 1mg tablet.
Magurol 2mg tablet.
Magurol 4mg tablet.
| Pharmaceutical Form |
|---|
|
Tablets for oral administration. 1mg: White or almost white, round, flat, tablets with diameter 7.0 mm. 2mg: White or almost white, round, flat, scored tablets with diameter 7.0 mm. 4mg: White or almost white, round, flat, scored tablets with diameter 8.5mm. |
Magurol 1 mg tablets: Each tablet contains doxazosin mesilate equivalent to 1 mg doxazosin.
Magurol 2 mg tablets: Each tablet contains doxazosin mesilate equivalent to 2 mg doxazosin.
Magurol 4 mg tablets: Each tablet contains doxazosin mesilate equivalent to 4 mg doxazosin.
Excipient with known effect: lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Doxazosin |
Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Magurol 1mg, 2mg, 4mg tablets are packed in PVC/aluminium foil blisters of seven or ten tablets.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Magurol tablets 1 mg/tablet: 17533
Magurol tablets 2 mg/tablet: 17534
Magurol tablets 4 mg/tablet: 17535
Magurol tablets 1 mg/tablet: 23.01.1998 / 24.10.2008
Magurol tablets 2 mg/tablet: 23.01.1998 / 24.10.2008
Magurol tablets 4 mg/tablet: 23.01.1998 / 17.09.2013
| Drug | Countries | |
|---|---|---|
| MAGUROL | Cyprus, Hong Kong, Lithuania, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
